S -Adenosyl- l -homocysteine in brain by Vunnam, Chouda Rani et al.
Neurochemical Research (2) 27-38 (1977) 
S - A D E N O S Y L - L - H O M O C Y S T E I N E  IN 
BRAIN 
Regional Concentrations, Catabolism, and the 
Effects of Methionine Sulfoximine 1 
ROBERT A. SCHATZ, CHOUDA R A N I  V U N N A M ,  A N D  
O T T O  Z .  S E L L I N G E R  
Laboratory of  Neurochemistry 
Mental Health Research Institute 
University of  Michigan Medical Center 
Ann Arbor, Michigan 48109 
Accepted September 1, 1976 
Administration of methionine sulfoximine (MSO) to rats and mice significantly 
decreased cerebral levels of S-adenosyl-L-homocysteine (AdoHcy). Concurrent 
administration of methionine prevented this decrease and, when methionine was 
given alone, significantly elevated AdoHcy levels resulted in both species. 
Regionally, AdoHcy levels varied from 20 nmol/g in rat cerebellum and spinal 
cord to about 60 nmol/g in hypothalamus and midbrain. MSO decreased 
AdoHcy in all regions tested except striatum, midbrain, and spinal cord. 
AdoMet/AdoHcy ratios (methylation index) varied from 0.48 in hypothalamus to 
2.4 in cerebellum, and MSO administration decreased these ratios in all regions 
except hypothalamus. AdoHcy hydrolase activity was lowest in hypothalamus, 
highest in brainstem and, generally, varied inversely with regional AdoHcy 
levels. MSO decreased AdoHcy hydrolase activity in all regions except hypo- 
thalamus and spinal cord. Cycloleucine administration resulted in significantly 
decreased levels of mouse brain AdoHcy, whereas the administration of 
dihydroxyphenylalanine (DOPA) failed to affect AdoHcy levels. It is concluded 
that (a) cerebral AdoHcy levels are more tightly regulated than are those of 
AdoMet after MSO administration, (b) slight fluctuations of AdoHcy levels may 
be important in regulating AdoHcy hydrolase activity and hence AdoHcy 
catabolism in vivo, (c) the AdoMet/AdoHcy ratio reflects the absolute AdoMet 
concentration rather than the transmethylation flux, (d) the decreased AdoMet 
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levels in midbrain, cortex, and striatum after MSO with no corresponding 
decrease in AdoHcy suggest an enhanced AdoMet utilization, hence an in- 
creased transmethylation in the MSO preconvulsant state. 
I N T R O D U C T I O N  
Attempts to elucidate the mechanism(s) responsible for the seizure- 
producing properties of methionine sulfoximine (MSO) have demon- 
strated that this agent alters methylation processes in brain. Administra- 
tion of MSO resulted in (a) decreased levels of cerebral S-adenosylme- 
thionine (AdoMet) in the rat (1), (b) increased activity of histamine-N- 
methyltransferase (HMT) in rat and mouse brain (2), and (c) increased 
activity of catechol-O-methyltransferase (COMT) in rat brain (2,3). The 
lack of effect of MSO (in vivo or in vitro) on the activity of the enzyme 
responsible for AdoMet synthesis (ATP:L-methionine-S-adenosyltrans- 
ferase) (4,5), paired with the finding of the elevated cerebral HMT and 
COMT activity (in vivo) (2), has led to the suggestion that MSO acts by 
increasing the flux through methylation pathways (2). The product of 
these methylations, S-adenosylhomocysteine (AdoHcy), has been pro- 
posed as a regulator of the activities of HMT (6,7), COMT (8), 
indolethylamine-N-methyltransferase (9), tRNA methyltransferases 
(10,11), and phenylethanolamine-N-methyltransferase (12). 
This investigation is concerned with the effect of MSO on AdoHcy 
levels and on the activity (in vivo) of the enzyme that hydrolyzes 
AdoHcy to adenosine and homocysteine (AdoHcy hydrolase, E.C. 
3.3.1.1.). The effect of methionine on the above parameters was also 
studied since methionine antagonizes MSO seizures (13,14) as well as 
the biochemical alterations in AdoMet (1), HMT, and COMT (2). 
AdoHcy levels after the administration of dihydroxyphenylalanine 
(DOPA) and cycloleucine were also determined since both agents 
decrease brain AdoMet , the former by increasing the utilization of 
methyl groups (15,16), and the latter by inhibiting AdoMet synthesis 
(16,17). Further, these two drugs, although they markedly decrease 
AdoMet levels, do not produce seizures. In fact, in the doses we have 
used, DOPA and cycloleucine injected concurrently with MSO confer 
some degree of protection against MSO seizures (Schatz and Sellinger, 
unpublished work). 
We have also investigated the validity of using the AdoMet/AdoHcy 
ratio as an index of transmethylation activity of brain tissue, as has been 
previously suggested (2,7). 
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E X P E R I M E N T A L  P R O C E D U R E  
Animals. Adult male Sprague-Dawley rats (120-200 g) and adult male Swiss-Webster 
mice (25-32 g) were obtained from Spartan Research Animals, Haslett, Michigan. 
Materials. S-adenosyl-L-homocysteine (AdoHcy), L-methionine, and L-methionine d,I- 
sulfoximine (MSO) were obtained from Sigma Chemical Co. (St. Louis, Missouri), 
adenosine from P-L Biochemicals Inc. (Milwaukee, Wisconsin), L-dihydroxyphenylalanine 
(DOPA), O,L-homocysteine, and L-methionine from ICN Nutritional Biochemicals 
(Cleveland, Ohio), radioactive adenosine [8-C 14] (sp act 52 mCi/mmol), PCS (a tissue 
solubilizer-scintillant mixture) from Amersham Searle (Arlington Heights, Illinois), silica 
gel and cellulose TLC plates F-254 (with fluorescent indicator) from EM Laboratories 
(Elmsford, New York), and Dowex 50W-X8 (200-400 mesh) and disposable glass barrel 
chromatography columns (0.7 x 10 cm) from Bio-Rad Laboratories (Richmond, Califor- 
nia). Cycloleucine (18) was generously supplied by Dr. R. Zand, Biophysics Division, 
Institute of Science and Technology, University of Michigan. 
Drug Treatment and Tissue Preparation. Rats or mice were injected intraperitoneally 
with saline (10 ml/kg), MSO (0.94 mmol/kg), methionine (4.7 mmol/kg), or a combination 
of MSO pl.us methionine, and sacrificed by decapitation. For regional analyses, rat brains 
were rapidly dissected on ice (19). Whole brains or brain regions were frozen in liquid N2 
and stored at -65~ unti! analyzed for AdoHcy content. 
For measurement of AdoHcy hydrolase activity, whole brains or brain regions were 
homogenized in 5 vol of 0.05 M potassium phosphate buffer (pH 7.4) and centrifuged at 
35,000g for 20 min. These supernatants were used as the source of AdoHcy hydrolase. 
Analytical. Radioactive AdoHcy was prepared from adenosine [8-C 14] and homocy- 
steine using rat liver enzyme purified up to the dialyzed 40-55% ammonium sulfate fraction 
(20). The enzyme reaction was stopped by addition of 1 N perchloric acid. After 
neutralization (pH 7) of perchloric acid supernatants with 10 N and 1 N KOH, the samples 
were centrifuged at 9000g for 10 rain. The supernatants were lyophilized, dissolved in a 
small volume of water, streaked on Whatman #3 paper, and run in ethanol-acetic acid- 
water (65 : 1 : 34) for a distance of 36 cm. The dried chromatograms were inspected under 
UV light, and the streak containing AdoHcy was cut out and eluted with water and 
sonication. After successive filtration through GF/A and Millipore 10-tzm filters the 
AdoHcy samples were again lyophilized. After lyophilization the samples were dissolved 
in water, and the sulfur content (21) and radioactivity of the samples were measured for 
determination of specific activity. The sulfur content of AdoHcy samples was compared to 
AdoHcy standards. The sulfur assay is sensitive to 0.01/xmol of AdoHcy. No impurities 
could be detected in AdoHcy samples chromatographed in ethanol-acetic acid-water 
(65 : 1 : 34) on silica and Whatman #1 paper, in ethanol-1 M ammonium acetate (70 : 30) 
on cellulose and silica, and in n-butanol-acetic acid-water (60 : 17 : 25) on paper. The 
AdoHcy on the chromatograms was identified by UV light, chloroplatinate spray for 
sulfur compounds, and ninhydrin spray (0.25% in acetone) for amino acids. 
AdoHcy levels were measured using a scaled-down isotope dilution method (1,22,24). 
To frozen brains or brain regions (pooled from 4 rats) were added AdoHcy [8-C 14] (sp act 
1-7 • 105 dpm/txmol) (50 nmol AdoHcy/g tissue) and 1.5-3 ml 1 N perchloric acid. After 
homogenization, the samples were centrifuged at 9000g for 10 min, the supernatants were 
adjusted to pH 11 using 10 N and 1 N KOH and stirred for 15 min at room temperature to 
destroy the alkali-labile AdoMet, the pH was readjusted to 7 with 1 N and 0.1 N 
perchloric acid, after which the samples were centrifuged at 9000g for 10 min. These 
supernatants were stored frozen at -65~ After thawing, the samples were put on Dowex 
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50 columns (0.7 x 1.5 or 3 cm) in the H + form (23) previously equilibrated with 1 N HCI. 
The columns were eluted with 2 N HCI until the absorbance at 256 nm was less than 0.02. 
Elution was continued with water (10 ml) followed by 3 N NH4OH (24). From 5 ml to 9 ml 
of the NH4OH eluate was lyophilized and dissolved in 0.5 ml HzO, to which was added 
2.5 ml sulfur reagent (21) and the absorbance at 500 nm measured. Five milliliters PCS was 
added to 0.5 ml of sample after the sulfur reaction for counting. Counting efficiency was 
determined using the channels ratio technique. Recovery of AdoHcy in the NH4OH 
eluates was from 50% to 70%. Two standards were carried through the experimental 
procedure each day. The purity of eluates was monitored as described above. In addition, 
samples were run bidimensionally [ethanol-acetic acid-water, 65 : 1 : 34 and acetone- 
water, 80 : 20 (25)] on silica and cellulose F-254 plates and no impurities were detectable. 
Further, samples of other sulfur-containing compounds (glutathione, L-cysteic acid, 
cystathionine, MSO, AdoMet, methionine, L-cysteine, L-cystine, D,e-homocysteic acid, 
and taurine) were carried through the experimental procedure and no interference was 
detected. This scaled-down isotope-dilution technique in combination with the sensitivity 
of the sulfur reagent C01/xmol AdoHcy) allowed measurement of AdoHcy content in 300 
mg tissue (assuming an AdoHcy level of 60 nmol/g tissue and 50% loss of AdoHcy during 
assay). 
AdoHcy hydrolase activity was measured in the direction of hydrolysis using radioac- 
tive AdoHcy [8-C ~4] as a substrate and 35,000g supernatant as enzyme source (20,26). 
Studies were conducted using this relatively crude, nondialyzed enzyme preparation since 
we had previously noted that dialysis reduced the elevation of HMT activity (2) seen after 
in vivo MSO administration, and we therefore reasoned that dialysis or further purification 
of AdoHcy hydrolase might remove any effects produced by MSO administration. Kinetic 
studies using 240-fold purified AdoHcy hydrolase (Schatz, Vunnam, and Sellinger, unpub- 
lished results) are at present under way. AdoHcy concentration was 320/xM in all cases. 
The reaction was linear for the time and enzyme concentrations used. Heated enzyme 
(90~ for 5 min) Was used as blank and incubations were for 15 rain and were stopped by 
heating, after which the tubes were centrifuged (9000g for 10 min) to remove any 
suspended material. The supernatants were lyophilized, dissolved in 75 t~l of water, and 
aliquots were spotted on Whatman #3 paper along with adenosine, inosine, and hypoxan- 
thine and run (18 cm) in ethanol-acetic acid-water (65 : 1 :34) .  The Rr values of these 
compounds are approximately the same in this solvent and clearly separated as one large 
spot from the substrate (AdoHcy). The chromatograms were dried, the reaction products 
were visualized by UV light, cut from the chromatograms, added to scintillation vials 
containing 1 ml H20, and sonicated for 10 min, after which 10 ml PCS was added and the 
vials counted. The amount of product(s) formed was calculated using the specific activity 
of AdoHcy (1-7 x 105 dprrg/xmol) and results are reported as nmol AdoHcy hydrolyzed/ 
mg proteirdh. 
Protein was measured in duplicate by the Lowry procedure (29). 
Statistical Analyses. Statistical comparisons were made using the two-tailed Student's t 
test. 
R E S U L T S  
T h r e e  h o u r s  a f t e r  M S O  a d m i n i s t r a t i o n ,  A d o H c y  l e v e l s  w e r e  d e -  
c r e a s e d  b y  15% in  r a t  b r a i n  ( T a b l e  I) a n d  2 7 %  in  m o u s e  b r a i n  ( T a b l e  I I ) .  
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TABLE I 
EFFECT OF METHIONINE OR METHIONINE SULFOXIMINE ON WHOLE RAT BRAIN 
S-ADENOSYLHOMOCYSTEINE LEVELS a 
Treatment nmol AdoHcy/g brain % Change P 
Saline 46.3 -+ 1.4 (10) - - 
MSO 39.5 + 1.4 (10) -15 <0.01 
Methionine 54.1 -+ 3.8 (5) +17 <0.01 
MSO + methionine 49.1 -+ 0.7 (5) +6 NS 
a Rats were injected intraperitoneally with saline (10 ml/kg), MSO (180 mg/kg), methionine 
(700 mg/kg), or MSO + methionine 3 h prior to sacrifice. AdoHcy values are expressed 
as means - SE in (N) determinations. Percent change values are as compared to saline 
treated animals. P values were determined by the 2-tailed Student's t test. P values 
>0.05 were considered not significant (NS). 
Conve r se ly ,  m e t h i o n i n e  admin i s t r a t ion  e leva ted  A d o H c y  levels  in rat  
(17%) and  mouse  b ra in  (30%). W h e n  both  agents  were  g iven  concur -  
rent ly ,  no changes  in A d o H c y  were observed .  Tables  I and  I I  also show 
that  A d o H c y  levels  of mouse  and  rat b ra in  va ry  on ly  slightly,  those of  
mouse  being 1.5-fold higher.  
Lowes t  A d o H c y  va lues  obse rved  were  in spinal  cord (16.5 nmol/g)  
(Table  I I I ) .  Regional  var ia t ion  in A d o H c y  levels  was modera te ,  ranging 
f rom a low of 20 nmol /g  in ce rebe l lum to a high of  abou t  60 nmol /g  in 
h y p o t h a l a m u s  and  midbra in .  The  effect of  M S O  on  regional  A d o H c y  
levels was qui te  var iable .  M S O  signif icant ly  dec reased  A d o H c y  in 
b ra ins t em,  h y p o t h a l a m u s ,  and  ce rebe l lum (28-38%),  modera t e ly  de- 
c reased  A d o H c y  in cor tex  and  h i p p o c a m p u s  (11% and  17%, respec-  
t ively),  and  had no effect in s t r ia tum,  midbra in ,  and  spinal  cord  (Tab le  
I l l ) .  
TABLE II 
EFFECT OF METHIONINE OR METHIONINE SULFOXIMINE ON WHOLE MOUSE 
BRAIN S-ADENOSYLHOMOCYSTEINE LEVELS a 
Treatment nmol AdoHcy/g brain % Change P 
Saline 69.7 -+ 1.3 (5) - - 
MSO 51.1 - 6.8 (6) -27 <0.025 
Methionine 90.4 -+ 6.2 (6) +30 <0.01 
MSO + methionine 74.4 -+ 6.3 (5) +7 NS 
Drug treatment, sacrifice time, and expression of results are as in Table I. 
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T A B L E  I I I  
E F F E C T  OF M E T H I O N I N E  S U L F O X I M I N E  ON S - A D E N O S Y L H O M O C Y S T E I N E  L E V E L S  
IN R A T  B R A I N  R E G I O N S  A N D  S P I N A L  C O R D  a 
R e g i o n  T r e a t m e n t  n m o l  A d o H c y / g  b r a i n  % C h a n g e  P 
C e r e b e l l u m  Sa l ine  19.9 -+ 1.6 (5) - - 
M S O  12.4 -+ 1.6 (5) - 3 8  < 0 . 0 1  
B r a i n s t e m  Sa l ine  47 .6  -+ 1.4 (5) - - 
M S O  34 .4  -+ 3 .9  (5) - 2 8  < 0 . 0 1  
S t r i a t u m  Sa l ine  48 .4  + 4 .2  (4) - - 
M S O  44.1 + 5 .4  (4) - 9  N S  
H y p o t h a l a m u s  Sa l ine  58.1 -+ 2 .4  (4) - - 
M S O  40 .7  --- 4.1 (4) - 3 0  < 0 . 0 0 5  
M i d b r a i n  Sa l i ne  59.1 -+ 2.5 (4) - - 
M S O  62.8 -+ 2 .7  (4) + 6  N S  
H i p p o c a m p u s  Sa l ine  46 .4  --- 7.3 (5) - - 
M S O  38 .6  - 5 .6  (5) - 1 7  N S  
C o r t e x  Sa l ine  47.5  - 3.2 (5) - - 
M S O  42 .2  _+ 3.3 (5) - 1 1  N S  
Sp ina l  c o r d  Sa l i ne  16.5 -+ 2 .6  (5) - - 
M S O  16.4 -+ 0.3 (5) 0 N S  
M S O  t r e a t m e n t ,  s ac r i f i c e  t i m e ,  a n d  e x p r e s s i o n  o f  r e su l t s  a r e  as  in T a b l e  I. R e g i o n s  f r o m  
the  b r a i n s  o f  f o u r  r a t s  w e r e  u s e d  f o r  e a c h  d e t e r m i n a t i o n .  
AdoHcy hydrolase activity was lowest in hypothalamus, highest in 
brainstem (28-45 nmol/mg protein/h) (Table IV) and, generally, varied 
inversely with regional AdoHcy concentration (Table III). MSO treat- 
ment markedly decreased AdoHcy hydrolase activity (23-47%) in all 
regions except the hypothalamus and the spinal cord, where the enzyme 
activity was slightly increased (Table IV). 
Regional rat brain AdoMet/AdoHcy ratios [using AdoMet data from 
(1) and AdoHcy data from Table III] varied from 0.48 in the hypothala- 
mus to 2.4 in the cerebellum, the next highest being in the striatum (1.02) 
(Table V). After MSO administration, AdoMet/AdoHcy ratios were 
decreased in all regions except the hypothalamus. This decrease was 
greatest in midbrain, cortex, and striatum (43-49%) and less marked in 
cerebellum, brainstem, and hippocampus (13-24%) (Table V). 
Administration of DOPA to mice did not significantly decrease 
AdoHcy levels, whereas significant decreases in AdoHcy were seen 
after cycloleucine (16-19%) (Table VI). The reduction of AdoHcy levels 
was approximately the same whether mice were sacrificed 1 h or 3 h 
after drug treatment (Table VI). 
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T A B L E  IV 
EFFECT OF METHIONINE SULFOXIMINE ON THE ACTIVITY OF S- 
ADENOSYLHOMOCYSTEINE HYDROLASE IN RAT BRAIN, BRAIN REGIONS, AND 
SPINAL CORD a 
Region Treatment AdoHcy hydrolase % Change P 
Cerebellum Saline 39.5 • 4.3 (6) 
MSO 22.6 • 5.2 (5) -43  <0.025 
Brainstem Saline 45.2 • 4.9 (6) 
MSO 23.8 • 4.3 (4) -47  <0.025 
Striatum Saline 36,6 • 1.7 (5) 
MSO 26.1 • 4.3 (5) -29  <0.05 
Hypothalamus Saline 28.3 • 8.4 (6) 
MSO 33.3 • 11.7 (5) +18 NS 
Midbrain Saline 32.8 • 4.9 (5) 
MSO 24.7 • 6.2 (5) -25 NS 
Hippocampus Saline 29.7 • 2.8 (4) 
MSO 14.0 • 4.4 (4) -53 <0.0125 
Cortex Saline 39.3 • 4.5 (4) 
MSO 30.2 • 3.9 (4) -23 NS 
Whole brain Saline 36.4 • 2.8 (6) 
MSO 26.0 • 3.2 (5) -29  <0.025 
Spinal cord Saline 38.1 • 4.2 (6) 
MSO 42.7 • 9.2 (5) +12 NS 
Enzyme activity is expressed as nmol AdoHcy hydrolyzed/mg protein/h and are the 
means • SE of (N) determinations. For explanation of percent change and P value see 
Table I. Time after MSO or saline, 3 h. 
T A B L E  V 
THE EFFECT OF METHIONINE SULFOXIMINE ON S-ADENOSYLMETHIONINE/S- 
ADENOSYLHOMOCYSTEINE RATIOS (METHYLATION INDEX) IN RAT BRAIN AND 
BRAIN REGIONS a 
Region Saline MSO % Change 
Cerebellum 2.40 (48/20) 2.08 (25112) - 13.5 
Brainstem 0.67 (32/48) 0.58 (20/34) - 14.0 
Striatum 1.02 (49/48) 0.52 (23/44) -49.0 
Hypothalamus 0.48 (28/58) 0.53 (22/41) + 10.0 
Midbrain 0.46 (27/59) 0.26 (17/63) -43.5 
Hippocampus 0.74 (34/46) 0.56 (22/39) -24.5 
Cortex 0.68 (32/47) 0.36 (15/42) -47.0 
Whole brain 0.80 (37/46) 0.51 (20/39) -36.5 
a All values are 3-h values with the exception of hypothalamic AdoMet (6 h). AdoMet data 
is from (1). Numbers in parentheses are AdoMet/AdoHcy values in nmol/g. 
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T A B L E  V I  
EFFECT OF L-DIHYDROXYPHENYLALANINE OR CYCLOCLEUCINE ON WHOLE 
MOUSE BRAIN S-ADENOSYLHOMOCYSTEINE LEVELS a 
Trea tment  Time (h) nmol  AdoHcy/g  brain % Change P 
Saline 1 or 3 72.0 _+ 3.1 (8) - - 
D O P A  1 63.7 + 5.1 (5) - 1 2  NS 
3 64.8 _+ 5.1 (6) - 1 0  NS 
Cycloleucine 1 58.6 _+ 2.5 (6) - 19 <0.005 
3 60.1 -+ 0.9 (6) - 1 6  <0.005 
a Mice were injected intraperitoneally with saline (10 ml/kg), L-3,4-dihydroxyphenylalanine 
(200 mg/kg) or cycloleucine (600 mg/kg) 1 or 3 h prior to sacrifice. A d o H c y  values  are 
expressed  as means  +- SE in (N) determinat ions.  Since saline injection at 1 or  3 h 
resulted in no statistically significant effect on A d o H c y  levels, 1- and 3-h saline values 
were pooled. For  explanat ion of percent  change and P value see Table 1. 
DISCUSSION 
There is a paucity of information concerning AdoHcy levels in 
nervous tissue. Rabbit brain AdoHcy content (52 nmol/g) (22) is interme- 
diate between that of rat and mouse brain (Tables I and II). Regional 
AdoHcy levels have previously not been reported (Table III). Since 
AdoHcy was found not to have the same regional distribution in rat 
brain as AdoMet (1) quite different regional AdoMet/AdoHcy ratios 
were obtained (Table V). Regional AdoHcy values (Table III) did 
appear, however, to be inversely related to AdoHcy hydrolase activity 
(Table IV). In mouse brain, which was found to contain significantly 
higher amounts of AdoHcy than rat or rabbit brain, AdoHcy hydrolase 
activity was too low to be accurately determined by the methods 
employed herein. This extreme inverse correlation suggests a prominent 
role for this enzyme in regulating cellular AdoHcy levels and thus, 
indirectly, AdoMet-dependent reactions such as those catalyzed by 
HMT (2) and COMT (8). No such relationship was shown to hold 
between the concentration of AdoMet and the activities of HMT (1) and 
COMT (30). 
The increase in cerebral AdoHcy levels after methionine noted in 
both the mouse and the rat (Tables I and II) has also been reported in 
rabbit brain (22). Conversely, the administration of MSO resulted in 
decreased AdoHcy levels in rat and mouse brain, this decrease being 
prevented by the concurrent administration of methionine (Tables I and 
II). The increased AdoHcy after methionine and decreased AdoHcy 
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after MSO, and cycloleucine (Table VI), although similar to the same 
changes noted for AdoMet (1,15,16), were much less marked, indicating 
that cellular AdoHcy levels are under a more tightly regulated control 
than are those of AdoMet. 
Since both MSO and DOPA have been proposed as causing an 
increased transmethylation flux (1,2,15), it was expected that, as 
AdoMet utilization accelerated, AdoHcy levels would increase rather 
than decrease. The observed decrease of AdoHcy after MSO may 
receive a tentative explanation by involing kinetic considerations relat- 
ing to the affinity of brain AdoHcy hydrolase for AdoHcy. The reported 
apparent K,~ values for AdoHcy of AdoHcy hydrolase from a number of 
sources are as follows: 41 /xM, spinach beet (27); 33 /xM, rat small 
intestine (28); 30 /xM, rat liver (28); and about 40 ~M, rat brain 
supernatant, and 240-fold purified AdoHcy hydrolase from the latter 
source (Schatz, Vunnam, and Sellinger, unpublished results). Since the 
cerebral AdoHcy levels were found to be in the same molar concentra- 
tion range (Tables I and III) as the apparent Km values for AdoHcy,  the 
reduction of AdoHcy hydrolase activity seen after MSO (Table IV) is a 
direct reflection of the close dependence of the AdoHcy hydrolase 
activity on the endogenous AdoHcy levels. In view of the fact that the 
enzyme also acts in reverse, i.e., it synthesizes AdoHcy,  and that it is 
highly sensitive to both end products of the synthetic and the hydrolytic 
reactions (20,26,27), further studies are necessary to fully ascertain the 
importance of AdoHcy hydrolase in the regulation of AdoHcy metabo- 
lism and thereby in the more general context of its role in the control of 
transmethylation in brain tissue. 
Since AdoHcy levels appeared more resistant to changes by drug 
treatment than were the levels of AdoMet (1,15,16), the applicability of 
the AdoMet/AdoHcy ratio as a cellular methylation index (1,7) seems 
doubtful. Rather, this ratio is a reflection of the absolute levels of 
AdoMet which are per se indicative of the state of flux of cellular 
transmethylation reactions. The situation encountered in the striatum, 
the cortex, and the midbrain (Table V) thus becomes a real measure of 
an enhanced AdoMet utilization, since in these regions AdoMet levels 
were decreased by MSO (1) while those of AdoHcy remained un- 
changed. 
Although cycloleucine and DOPA also deplete cerebral AdoMet they 
do so by different mechanisms. Cycloleucine effectively decreases 
methylation (16) because it inhibits AdoMet synthesis (4,17) and may 
also inhibit AdoHcy formation (Table VI). DOPA, on the other hand, 
competes with other methyl acceptors for AdoMet and consequently 
reduces the methylations of histamine (7,32) and norepinephrine (32,33). 
36 SCHATZ ET AL. 
These and presumably other as yet unidentified effects of DOPA and 
cycloleucine on cellular methylation could account for the partial 
protective effect these substances exerted against MSO. An alternative 
explanation of this protective effect may be that DOPA and cycloleu- 
cine, like methionine (34,35), compete with MSO for uptake into 
cerebral tissue. DOPA has been shown to compete with methionine for 
uptake into synaptosomes (36), and, speculatively, this may hold true for 
cycloleucine as well. Some support for this notion was presented by 
Zand et al. (18), who noted that the intraperitoneal administration of a 
number of cyclic and bicyclic amino acids results in a marked reduction 
of cerebral methionine and, in two cases, in marked increases of brain 
cysteine. Finally, the possibility exists that the MSO-induced regional 
deficits in either AdoMet or AdoHcy may underlie regional deficiencies 
of methionine and/or homocysteine. Although for methionine we have 
previously shown that soon after MSO administration there is a signifi- 
cant elevation of its cerebral levels which progressively return to normal 
values within 4 h (37), no data are available for homocysteine, the 
cerebral levels of which are to date unknown. 
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